Ofloxacino Altan

Ofloxacin, the active ingredient in Ofloxacino Altan, is a fluoroquinolone antibiotic presented as a tablet for oral use. It treats a variety of bacterial infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Ofloxacino Altan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ofloxacino Altan is a broad‑spectrum antibacterial that targets common bacterial pathogens in several organ systems. - Urinary tract infection: helps eradicate the causative bacteria and relieve symptoms. - Respiratory tract infection: aids in clearing bacterial pneumonia and bronchitis. - Skin and soft‑tissue infection: assists in eliminating staphylococcal and streptococcal organisms. - Gonorrhoea: provides effective bacterial eradication in uncomplicated cases. - Prostatitis chronic bacterial: contributes to bacterial clearance in chronic prostatitis. - Eye infections (topical formulation): treats bacterial conjunctivitis and keratitis.

Adverse reactions to Ofloxacino Altan vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: watery stools, often self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Rash: mild skin erythema or itching. - Photosensitivity: increased skin reaction to sunlight.

Serious or Rare Side Effects: - Tendon rupture: sudden pain or loss of function, especially in the Achilles. - Peripheral neuropathy: tingling, numbness or weakness in extremities. - QT interval prolongation: cardiac rhythm disturbances detectable on ECG. - Severe hypersensitivity: anaphylaxis, angio‑edema or Stevens‑Johnson syndrome. - Hepatotoxicity: elevated liver enzymes or jaundice. - Clostridioides difficile infection: severe colitis following dysbiosis.

When prescribing Ofloxacino Altan, clinicians should consider several safety aspects. - Renal impairment: adjust dose in patients with reduced kidney function. - Hepatic impairment: use with caution in liver disease. - Pregnancy: avoid use unless clearly needed, as animal studies show risk. - Age >65 years: monitor for tendon and CNS effects. - Concomitant QT‑prolonging drugs: assess cardiac risk. - Store below 25°C: keep in the original container, protect from moisture and light.

Ofloxacino Altan may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminium or magnesium: reduce absorption of ofloxacin. - Warfarin: may increase INR values and bleeding risk. - Theophylline: elevated plasma levels can cause toxicity. - Cyclosporine: increased risk of nephrotoxicity. - NSAIDs (non‑selective): higher chance of CNS stimulation.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in contraceptive effectiveness.\n- Diabetic agents: may affect blood glucose control. - Corticosteroids: increased risk of tendon injury. - Antidepressants (SSRIs): potential for QT prolongation. - Iron supplements: may diminish ofloxacin absorption.